申请人:CHEMOCENTRYX INC
公开号:WO2014085490A1
公开(公告)日:2014-06-05
Compounds having formula (I) (structurally represented) or pharmaceutically acceptable salts, hydrates or N-oxides thereof are provided and are useful for binding to CXCR7, and treating diseases that are dependent, at least in part, on CXCR7 activity. Accordingly, the present invention provides in further aspects, compositions containing the compounds in admixture with a pharmaceutically acceptable excipient.